GC
XYL icon

Grimes & Company’s Xylem XYL Stock Holding History

Grimes & Company’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.68M Sell
56,507
-1,874
-3% -$216K 0.14% 100
2026
Q1 		$6.98M Sell
58,381
-1,676
-3% -$220K 0.19% 93
2025
Q4 		$8.18M Sell
60,057
-5,386
-8% -$775K 0.2% 90
2025
Q3 		$9.65M Sell
65,443
-10,176
-13% -$1.41M 0.24% 78
2025
Q2 		$9.78M Sell
75,619
-34,011
-31% -$4.12M 0.27% 77
2025
Q1 		$13.1M Buy
+109,630
New +$13.6M 0.4% 60

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Grimes & Company's XYL Position: Q2 2026 in Review

Grimes & Company reduced its Xylem (XYL) stake by 3.2% in Q2 2026, selling an estimated $216K and leaving 56,507 shares worth $6.68M. The position accounts for 0.14% of the portfolio, ranked #100.

Grimes & Company first reported a position in XYL in Q1 2025 and has held it in 6 quarters since. The position peaked at $13.1M in Q1 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Grimes & Company held 56,507 shares of Xylem worth $6.68M as of Q2 2026.
  • Grimes & Company sold 1,874 Xylem shares in Q2 2026, an estimated $216K.
  • Xylem made up 0.14% of Grimes & Company's portfolio in Q2 2026, its #100 holding.
  • Grimes & Company first reported a position in Xylem in Q1 2025 and has held it in 6 quarters since.
  • Grimes & Company's Xylem position peaked at $13.1M in Q1 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.